documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
113 rows where docket_id = "FDA-1975-N-0336" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
agency_id 1
- FDA 113
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0336-0121 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Drugs for Human Use; Drug Efficacy Study Implementation; Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination With a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation | Notice | Announcement | 2022-04-25T04:00:00Z | 2022 | 4 | 2022-04-25T04:00:00Z | 2022-04-25T12:23:39Z | 2022-08740 | 0 | 0 | 0900006485031b82 | |
| FDA-1975-N-0336-0102 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Extension from Carter-Wallace, Inc | Other | Request for Extension | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:15:53Z | 0 | 0 | 09000064805c7b49 | |||
| FDA-1975-N-0336-0104 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Carter-Wallace, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:16:58Z | 0 | 0 | 09000064805c7b4c | |||
| FDA-1975-N-0336-0107 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Extension of Time from Hoffman-La Roche, Inc. | Other | Request for Extension | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:18:55Z | 0 | 0 | 09000064805c7b50 | |||
| FDA-1975-N-0336-0108 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Hoffmann-La Roche, Inc. to FDA/DDM | Other | Letter(s) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:19:41Z | 0 | 0 | 09000064805c7b55 | |||
| FDA-1975-N-0336-0111 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Chelsea Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:22:45Z | 0 | 0 | 09000064805c7b74 | |||
| FDA-1975-N-0336-0112 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Cord Laboratories, Inc. to FDA/CDER | Other | Letter(s) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:23:32Z | 0 | 0 | 09000064805c7b76 | |||
| FDA-1975-N-0336-0113 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Premo Pharmaceutical Laboratories, Inc. to FDA/CDER | Other | Letter(s) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:24:10Z | 0 | 0 | 09000064805c7b77 | |||
| FDA-1975-N-0336-0114 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from Carter Wallace, Inc. (Kleinfeld, Kaplan and Becker) | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:25:38Z | 0 | 0 | 09000064805c7bf6 | |||
| FDA-1975-N-0336-0116 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal of Request for Hearing from Zenith Laboratories, Inc. | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:27:01Z | 0 | 0 | 09000064805c7c00 | |||
| FDA-1975-N-0336-0117 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal of Request for Hearing from Cord Laboratories, Inc. | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:27:53Z | 0 | 0 | 09000064805c7c01 | |||
| FDA-1975-N-0336-0119 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from Sandoz | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:30:27Z | 0 | 0 | 0900006484ea48a7 | |||
| FDA-1975-N-0336-0097 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Premo Pharmaceutical Laboratories, Inc. | Other | Letter(s) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:08:57Z | 0 | 0 | 09000064805c7b37 | |||
| FDA-1975-N-0336-0105 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Notice of Appearance and Request for Hearing from Hoffman-La Roche, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T05:00:00Z | 2021-12-07T16:17:34Z | 0 | 0 | 09000064805c7b4d | ||
| FDA-1975-N-0336-0109 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Supplement from Premo Pharmaceutical Laboratories, Inc. | Other | Supplement (SUP) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:21:04Z | 0 | 0 | 09000064805c7b66 | |||
| FDA-1975-N-0336-0110 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Supplement from Cord Laboratories, Inc (Hamel, Park, McCabe & Saunders) | Other | Supplement (SUP) | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:22:02Z | 0 | 0 | 09000064805c7b68 | |||
| FDA-1975-N-0336-0101 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Zenith Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:14:34Z | 0 | 0 | 09000064805c7b48 | |||
| FDA-1975-N-0336-0120 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from Teva Pharmaceuticals | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:30:55Z | 0 | 0 | 0900006484ea48cc | |||
| FDA-1975-N-0336-0099 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Notice of Appearance and Request for Hearing from Premo Pharmaceutical Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:11:38Z | 0 | 0 | 09000064805c7b46 | |||
| FDA-1975-N-0336-0106 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Endo Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:18:13Z | 0 | 0 | 09000064805c7b4f | |||
| FDA-1975-N-0336-0098 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Premo Pharmaceutical Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:09:43Z | 0 | 0 | 09000064805c7b38 | |||
| FDA-1975-N-0336-0100 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Notice of Appearance and Request for Hearing from Cord Laboratories, Inc. | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:12:40Z | 0 | 0 | 09000064805c7b47 | |||
| FDA-1975-N-0336-0103 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing from Lederle Laboratories | Other | Request for Hearing | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:16:36Z | 0 | 0 | 09000064805c7b4b | |||
| FDA-1975-N-0336-0115 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Pathibamate Tablets; Drugs for Human Use; Drug Efficacy Study Implementation; Withdrawal of Approval of New Drug Application | Notice | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:26:29Z | 52 FR 22687 | 0 | 0 | 09000064805c7bff | ||
| FDA-1975-N-0336-0118 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from Genentech, Inc. | Other | Withdrawal | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T16:29:39Z | 0 | 0 | 0900006484ea470a | |||
| FDA-1975-N-0336-0094 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | August 2, 1973 stipulation | Other | Additional Information | 2020-10-02T04:00:00Z | 2020 | 10 | 2020-10-02T04:00:00Z | 2020-10-02T18:34:22Z | 0 | 0 | 09000064848b8681 | ||
| FDA-1975-N-0336-0096 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | November 22, 2017 Hogan Lovells Letter (Valeant) | Other | Additional Information | 2020-10-02T04:00:00Z | 2020 | 10 | 2020-10-02T04:00:00Z | 2020-10-02T18:34:41Z | 0 | 0 | 09000064848b8683 | ||
| FDA-1975-N-0336-0095 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | May 23, 2016 to Hogan Lovells | Other | Additional Information | 2020-10-02T04:00:00Z | 2020 | 10 | 2020-10-02T04:00:00Z | 2020-10-02T18:34:31Z | 0 | 0 | 09000064848b8682 | ||
| FDA-1975-N-0336-0093 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | January 2, 1973 Complaint | Other | Additional Information | 2020-10-02T04:00:00Z | 2020 | 10 | 2020-10-02T04:00:00Z | 2020-10-02T18:34:10Z | 0 | 0 | 09000064848b7d5f | ||
| FDA-1975-N-0336-0092 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from FDA CDER to ECI Pharmaceuticals, LLC. | Other | Letter(s) | 2020-07-08T04:00:00Z | 2020 | 7 | 2020-07-08T04:00:00Z | 2020-07-08T19:48:02Z | 0 | 0 | 0900006484732879 | ||
| FDA-1975-N-0336-0091 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from ECI Pharmaceuticals, LLC | Other | Withdrawal | 2020-05-06T04:00:00Z | 2020 | 5 | 2020-05-06T04:00:00Z | 2020-05-06T16:44:04Z | 0 | 0 | 090000648455643a | ||
| FDA-1975-N-0336-0090 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Acknowledge Withdrawal of Request for Internal Agency Review - Virtus Pharmaceuticals LLC - Docket FDA 1975 N 0336 final | Other | Withdrawal | 2020-03-26T04:00:00Z | 2020 | 3 | 2020-03-26T04:00:00Z | 2020-03-26T13:13:35Z | 0 | 0 | 090000648446b5d1 | ||
| FDA-1975-N-0336-0087 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Withdrawal from Virtus Pharmaceuticals OPCO II, LLC (Husch Blackwell LLP) | Other | Withdrawal | 2020-01-28T05:00:00Z | 2020 | 1 | 2020-01-28T05:00:00Z | 2020-01-28T15:08:46Z | 0 | 0 | 09000064842f8665 | ||
| FDA-1975-N-0336-0081 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Acknowledgement Letter from CDER to Valeant Pharmaceuticals North America LLC | Other | Acknowledgement Letter/Receipt | 2017-10-11T04:00:00Z | 2017 | 10 | 2017-10-11T04:00:00Z | 2017-11-27T16:57:22Z | 0 | 0 | 0900006482bbe15a | ||
| FDA-1975-N-0336-0080 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Response Letter from Valeant Pharmaceuticals (Hogan Lovells LLP) to FDA CDER | Other | Letter(s) | 2017-09-26T04:00:00Z | 2017 | 9 | 2017-09-26T04:00:00Z | 2017-09-26T18:54:09Z | 0 | 0 | 0900006482b7dba4 | ||
| FDA-1975-N-0336-0079 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Acknowledgment Letter from FDA CDER to Virtus Pharmaceuticals OPCO II, LLC ( Buchanan Ingersoll & Rooney, PC) | Other | Acknowledgement Letter/Receipt | 2017-09-05T04:00:00Z | 2017 | 9 | 2017-09-05T04:00:00Z | 2017-09-05T18:32:41Z | 0 | 0 | 0900006482b03f7f | ||
| FDA-1975-N-0336-0078 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Internal Agency Review from Virtus Pharmaceuticals OPCO II, LLC ( Buchanan Ingersoll & Rooney, PC) | Other | Request | 2017-09-05T04:00:00Z | 2017 | 9 | 2017-09-05T04:00:00Z | 2024-11-07T01:10:44Z | 1 | 0 | 0900006482b03f7e | ||
| FDA-1975-N-0336-0077 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from FDA CDER to Hyman, Phelps and McNamara, P.C. | Other | Letter(s) | 2016-08-22T04:00:00Z | 2016 | 8 | 2016-08-22T04:00:00Z | 2016-08-22T18:14:59Z | 0 | 0 | 0900006482190241 | ||
| FDA-1975-N-0336-0076 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Valeant Pharmaceuticals North America, LLC to FDA/CDER | Other | Letter(s) | 2016-06-03T04:00:00Z | 2016 | 6 | 2016-06-03T04:00:00Z | 2017-12-05T20:14:21Z | 0 | 0 | 090000648200e1ec | ||
| FDA-1975-N-0336-0075 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Hyman, Phelps and McNamara, P.C. to FDA DDM | Other | Letter(s) | 2016-06-01T04:00:00Z | 2016 | 6 | 2016-06-01T04:00:00Z | 2016-06-01T17:46:20Z | 0 | 0 | 0900006482005b7c | ||
| FDA-1975-N-0336-0074 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA Notice to Docket Regarding Librax, DESI 10837 | Other | Memo | 2016-05-24T04:00:00Z | 2016 | 5 | 2016-05-24T04:00:00Z | 2016-06-06T20:14:14Z | 0 | 0 | 0900006481fe8f19 | ||
| FDA-1975-N-0336-0072 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Extention from Concordia Pharmaceuticals, Inc. (Buchanan Ingersoll Rooney PC) | Other | Request for Extension | 2015-05-14T04:00:00Z | 2015 | 5 | 2015-05-14T04:00:00Z | 2015-05-14T19:44:56Z | 0 | 0 | 0900006481ae101d | ||
| FDA-1975-N-0336-0073 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Response Letter from FDA CDER to Buchanan Ingersoll and Rooney PC | Other | Letter(s) | 2015-05-14T04:00:00Z | 2015 | 5 | 2015-05-14T04:00:00Z | 2015-05-14T19:38:54Z | 0 | 0 | 0900006481ae101e | ||
| FDA-1975-N-0336-0071 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from FDA CDER to Concordia Pharmaceuticals, Inc. | Other | Letter(s) | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T04:00:00Z | 2015-04-09T16:59:46Z | 0 | 0 | 0900006481a9826f | ||
| FDA-1975-N-0336-0070 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Supplement from PBM Pharmaceuticals, Inc. | Other | Supplement (SUP) | 2014-06-05T04:00:00Z | 2014 | 6 | 2014-06-05T04:00:00Z | 2014-06-05T16:20:18Z | 0 | 0 | 0900006481707b02 | ||
| FDA-1975-N-0336-0069 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | PBM Pharmaceuticals, Inc. - Report | Other | Report | 2013-10-30T04:00:00Z | 2013 | 10 | 2013-10-30T04:00:00Z | 2015-01-28T13:39:09Z | 0 | 0 | 090000648142e7ed | ||
| FDA-1975-N-0336-0062 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Phenobarbital_With_Atropine_597 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:46:03Z | 0 | 0 | 090000648124a813 | ||
| FDA-1975-N-0336-0066 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Robinol_PH_And_Robinol_PH_Forte_12_950 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:48:22Z | 0 | 0 | 090000648124a999 | ||
| FDA-1975-N-0336-0061 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Pamine_PB_Elixir_9_261 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:45:31Z | 0 | 0 | 090000648124a810 | ||
| FDA-1975-N-0336-0052 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Cantil_With_PB_10_679 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:40:35Z | 0 | 0 | 090000648124a365 | ||
| FDA-1975-N-0336-0048 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Bentyl_Repeat_Action_Tablets_With_Phenobarbital_9_311 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:37:32Z | 0 | 0 | 090000648124a318 | ||
| FDA-1975-N-0336-0047 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Valpin PB_Elixir_13-431 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:36:59Z | 0 | 0 | 090000648124a316 | ||
| FDA-1975-N-0336-0064 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Profenil_With_Phenobarbital_6_471 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:47:22Z | 0 | 0 | 090000648124a997 | ||
| FDA-1975-N-0336-0051 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Bentyl_Syrup_With_Phenobarbital_7_961 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:40:08Z | 0 | 0 | 090000648124a31e | ||
| FDA-1975-N-0336-0055 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_CO_Elorine_8_919 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:42:07Z | 0 | 0 | 090000648124a784 | ||
| FDA-1975-N-0336-0054 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Centrine_With_Phenobarbital_9_288 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:41:36Z | 0 | 0 | 090000648124a369 | ||
| FDA-1975-N-0336-0060 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Nactisol_12_741 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:45:04Z | 0 | 0 | 090000648124a80e | ||
| FDA-1975-N-0336-0068 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Tricolid_Tablets_8_910 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:49:30Z | 0 | 0 | 090000648124aa24 | ||
| FDA-1975-N-0336-0049 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Antrenyl_Bromide_8_492 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:39:00Z | 0 | 0 | 090000648124a31a | ||
| FDA-1975-N-0336-0057 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Daricon_PB_Tablets_13_515 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:43:47Z | 0 | 0 | 090000648124a788 | ||
| FDA-1975-N-0336-0067 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Tral_With_Phenobarbital_10_599 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:49:05Z | 0 | 0 | 090000648124a99d | ||
| FDA-1975-N-0336-0063 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Piptal_PHB_9_427 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:46:29Z | 0 | 0 | 090000648124a868 | ||
| FDA-1975-N-0336-0059 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Mondral_Bromide_9_032 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:44:39Z | 0 | 0 | 090000648124a80c | ||
| FDA-1975-N-0336-0058 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Metropine_With_Phenobarbital_4_298 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:44:13Z | 0 | 0 | 090000648124a78a | ||
| FDA-1975-N-0336-0050 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Bently_10_MGM_Capsules_With_Phenobarbital_7_409 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:39:36Z | 0 | 0 | 090000648124a31c | ||
| FDA-1975-N-0336-0056 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Dactil_With_Phenobarbital_8_907 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:43:19Z | 0 | 0 | 090000648124a786 | ||
| FDA-1975-N-0336-0053 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Centrine_Elixir_8885 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:41:08Z | 0 | 0 | 090000648124a367 | ||
| FDA-1975-N-0336-0065 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Pro_Banthine_With_Phenobarbital_9-014 | Other | Studies | 2013-03-28T04:00:00Z | 2013 | 3 | 2013-03-28T04:00:00Z | 2013-03-28T14:47:57Z | 0 | 0 | 090000648124a86c | ||
| FDA-1975-N-0336-0040 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Banthine_with_Phenobarbital_7_390 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T20:56:20Z | 0 | 0 | 0900006481247f62 | |||
| FDA-1975-N-0336-0046 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Trocinate _6_098 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:58:45Z | 0 | 0 | 0900006481248603 | ||
| FDA-1975-N-0336-0044 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Pathilion_Tridihexethyl_Chloride_with_Phenobarbital_Sequels_11_940 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:57:52Z | 0 | 0 | 090000648124801e | ||
| FDA-1975-N-0336-0043 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Pamine_PB_Tablets_8-942 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:57:30Z | 0 | 0 | 0900006481247ff4 | ||
| FDA-1975-N-0336-0041 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Bentyl_Injection_20mg_per_2cc_8-370 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:56:41Z | 0 | 0 | 0900006481247f6a | ||
| FDA-1975-N-0336-0042 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Pamine_PB_Drops_9-260 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:57:06Z | 0 | 0 | 0900006481247fad | ||
| FDA-1975-N-0336-0045 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Tral_with_Phenobarbital_11_200 | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T04:00:00Z | 2013-03-27T20:58:17Z | 0 | 0 | 090000648124804d | ||
| FDA-1975-N-0336-0039 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | NAS_NRC_Drug_Efficacy_Study_for_Valpin_Pb_Tablets_and_Blixir | Other | Studies | 2013-03-27T04:00:00Z | 2013 | 3 | 2013-03-27T20:55:43Z | 0 | 0 | 0900006481247ef7 | |||
| FDA-1975-N-0336-0037 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Supplement from PBM Pharmaceuticals, Inc. (Buchanan Ingersoll & Rooney PC) | Other | Supplement (SUP) | 2012-11-02T04:00:00Z | 2012 | 11 | 2012-11-02T04:00:00Z | 2017-12-05T21:55:01Z | 0 | 0 | 090000648115a3fb | ||
| FDA-1975-N-0336-0036 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Supplemental Information from PBM Pharmaceuticals, Inc. (Buchanan Ingersoll & Rooney PC) (Vol. 141-C) | Other | Supplement (SUP) | 2012-10-05T04:00:00Z | 2012 | 10 | 2012-10-05T04:00:00Z | 2017-12-05T21:46:35Z | 0 | 0 | 0900006481136b5a | ||
| FDA-1975-N-0336-0035 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from Valeant Pharmaceuticals North America LLC to FDA/CDER | Other | Letter(s) | 2012-10-02T04:00:00Z | 2012 | 10 | 2012-10-02T04:00:00Z | 2017-12-06T15:35:36Z | 0 | 0 | 09000064810f8657 | ||
| FDA-1975-N-0336-0033 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Memorandum of Telecon Between Pfizer Inc. and FDA/CDER | Other | Memorandum | 2012-08-30T04:00:00Z | 2012 | 8 | 2012-08-30T04:00:00Z | 2012-08-30T22:19:51Z | 0 | 0 | 0900006480f2629f | ||
| FDA-1975-N-0336-0034 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER to Buchanan Ingersoli & Rooney PC - Letter | Other | Letter(s) | 2012-08-30T04:00:00Z | 2012 | 8 | 2012-08-30T04:00:00Z | 2012-08-30T22:20:59Z | 0 | 0 | 09000064810c97ea | ||
| FDA-1975-N-0336-0032 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Drugs for Human Use; Drug Efficacy Study Implementation: Certain Prescription Drugs Offered for Various Indications; Opportunity to Affirm Outstanding Hearing Request | Notice | General Notice | 2012-07-24T04:00:00Z | 2012 | 7 | 2012-07-24T04:00:00Z | 2017-12-06T15:53:40Z | 2012-18015 | 0 | 0 | 09000064810ac248 | |
| FDA-1975-N-0336-0031 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products - Supplemental Information (Vol. 141-B) | Other | Request for Hearing | 2011-09-13T04:00:00Z | 2011 | 9 | 2011-09-13T04:00:00Z | 2017-12-05T21:44:07Z | 0 | 0 | 0900006480ee57db | ||
| FDA-1975-N-0336-0027 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Premo Pharmaceutical Labs, Inc., - [Sheppard Mulln Richter & Hampton LLP] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:20Z | 1 | 0 | 0900006480f08fee | ||
| FDA-1975-N-0336-0015 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Poythress Laboratories, Inc., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:38:48Z | 0 | 0 | 0900006480f08da7 | ||
| FDA-1975-N-0336-0030 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Cord Labs, Inc., - [Arent Fox LLP] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:49:09Z | 0 | 0 | 0900006480f08ff6 | ||
| FDA-1975-N-0336-0024 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Beecham Laboratories, DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:46:03Z | 0 | 0 | 0900006480f08fb3 | ||
| FDA-1975-N-0336-0026 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Premo Pharmaceutical. - [Teva Pharmaceuticals] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08fb7 | ||
| FDA-1975-N-0336-0017 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Reid-Provident Laboratories, Inc.'s., DESI 597 [ Abbott Laboratories] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:37Z | 1 | 0 | 0900006480f08ede | ||
| FDA-1975-N-0336-0019 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:31Z | 1 | 0 | 0900006480f08ee2 | ||
| FDA-1975-N-0336-0023 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to B.F. Ascher & Co., Inc., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08f95 | ||
| FDA-1975-N-0336-0025 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Richlyn Laboratories, Inc.., - [Impax Laboratories, Inc.] DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08fb5 | ||
| FDA-1975-N-0336-0021 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to West-Ward Pharmaceutical Corp., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2013-01-08T03:27:35Z | 0 | 0 | 0900006480f08f91 | ||
| FDA-1975-N-0336-0014 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to National Pharmaceuticals Manufacturing Co.,, DESI 597 - [ Actavis US] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f08da5 | ||
| FDA-1975-N-0336-0016 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Purepac Pharmaceutical's - [ Actavis ] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:39:08Z | 0 | 0 | 0900006480f08edc | ||
| FDA-1975-N-0336-0022 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to William Rorer, Inc., DESI 597 [ Sanofi-aventis U,S.] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:04Z | 1 | 0 | 0900006480f08f93 | ||
| FDA-1975-N-0336-0020 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Stuart Pharmaceuticals, DESI 597 - [ AstraZeneca Pharmaceuticals LP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:42:14Z | 0 | 0 | 0900006480f08f8d | ||
| FDA-1975-N-0336-0028 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Roche pharmaceutical, - [Genentech, Inc.] - DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:48:23Z | 0 | 0 | 0900006480f08ff0 | ||
| FDA-1975-N-0336-0029 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Roche Laboratories, - [Valeant Pharmaceuticals International, Inc] - DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:38Z | 1 | 0 | 0900006480f08ff4 | ||
| FDA-1975-N-0336-0018 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f08ee0 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);